Surge uses machine learning algorithms to decode a patient's immune system from a blood sample.
Surge has raised €10M across 2 funding rounds from 8 investors, most recently a round in Mar 2024. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2024-03-28 | Other | €7.5M | 50 Partners Santé,Boutique Venture,Eurazeo,HCVC,Kima,MH Innov’+1 more | View deal → |
| 2022-09-22 | Other | €2.5M | Boutique Venture,HCVC,Nicolas Godin | View deal → |
